Children receiving valid third dose of vaccines (DTP/Hep B/PCV/Hib/Rotavirus)

Indicator Name

% of children aged 12-23 months who received the valid third dose of DTP/Hep B/PCV/Hib/Rotavirus containing vaccine

Indicator ID in PRIME

IN00021494

Definition

Definition

This indicator measures the percentage of children aged 12-23 months who received the valid third dose of DTP/Hep B/PCV/Hib/Rotavirus containing vaccine.

For the dosage of these vaccines to be valid, vaccinations need to be administered within 28 days of each other.

Numerator

Number of children aged 12-23 months who received the valid third dose of DTP/Hep B/PCV/Hib/Rotavirus containing vaccine

Denominator

Total number of children aged 12-23 months in the target group for each vaccine

Recommended Means of Verification

There are two ways to measure this indicator.
(1) Looking at the following data sources for:
Numerator: program/project records, health facility immunization records, or national/sub-regional HMIS/DHIS.

Denominator: the country's national/sub-regional population estimates for the SC program/project intervention areas.

(2) Conducting individual interviews with a representative sample of mothers or caregivers of children aged 12-23 months, inquiring if their children received the third dose of DTP/Hep B/PCV/Hib/Rotavirus vaccine in the last specified time period. This information can be gathered via:

a) Vaccination Card:
Do you have a card or other document where [name]'s vaccinations are written down?
Did you ever have a vaccination card for [name]?
Record vaccination dates from vaccination card in a checklist containing the list of DTP/Hep B/PCV/Hib/Rotavirus vaccines with their respective doses 1,2,3.
Take note of number of children who received third doses.

or

b) Mother's report to the following questions:
Has [name] ever receive a [DTP/Hep B/PCV/Hib/Rotavirus] vaccine, that is, [brief explanation of purpose of vaccination]?
If yes, how many times did [name] receive the [DTP/Hep B/PCV/Hib/Rotavirus] vaccine?

To calculate the indicator's value, divide the number of children aged 12-23 months who received the valid third dose of DTP/Hep B/PCV/Hib/Rotavirus containing vaccine by the total number of children aged 12-23 months in the target group for each vaccine. Multiply the result by 100 to convert it to a percentage.

For the dosage of these vaccines to be valid, vaccinations need to be administered within 28 days of each other.

Indicator Attributes

Indicator Prioritisation

Global Indicator

Level of Indicator

Outcome

Indicator Context Type

Quantitative

Theme

Health & Nutrition

Sub Theme

Child Health

Common Approach

Treating Children Close to Home (Integrated Community Case Management)

Total Reach Indicator

No

Context

Development

Measurement GuidanceĀ 

Frequency of Data Collection

Annually

Unit of Measure

Individual

Data Format

Percent

Direction of Desired Change

Increasing

Number of Decimal Points

Zero

Indicator is Rounding

No

Nature

Cumulative

Recommended Disaggregations

Gender Group TR

Tools

Do you have a card or other document where [name]'s vaccinations are written down?
Did you ever have a vaccination card for [name]?

Has [name] ever receive a [DTP/Hep B/PCV/Hib/Rotavirus] vaccine, that is, [brief explanation of purpose of vaccination]?
If yes, how many times did [name] receive the [DTP/Hep B/PCV/Hib/Rotavirus] vaccine?

This guidance was prepared by Sheetal Rahi Lookhar ©

Propose Improvements